** Shares of Tylenol maker Kenvue KVUE.N rise 2.13% to $23.24
** Dan Loeb's Third Point has built a stake in the company, the Financial Times reports, citing people familiar with the matter
** The size of Third Point's stake and the extent to which the hedge fund has engaged with Kenvue could not immediately be established, FT said
** Kenvue did not immediately respond to a Reuters request for comment
** In March, Kenvue appointed three new directors to its board as part of an agreement with activist investor Starboard Value
** Up to last close, stock has risen 9.7% YTD
(Reporting by Sriparna Roy in Bengaluru)
((Sriparna.Roy@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.